LDR Files Registration Statement for Proposed Initial Public Offering (press release)
LDR Holding, which develops medical devices for use in spine surgery, announced terms for its IPO on Thursday. The Austin, TX-based company plans to raise $75 million by offering 5.0 million shares at a price range of $14 to $16. At the midpoint of the proposed range, LDR Holding would command a fully diluted market value of $364 million.
LDR Holding, which was founded in 2000 and booked $98 million in sales for the 12 months ended June 30, 2013, plans to list on the NASDAQ under the symbol LDRH. LDR Holding initially filed confidentially on June 5, 2013. Piper Jaffray, William Blair and Bryan, Garnier & Co are the joint bookrunners on the deal.
LDR Holding Corporation announced today that it has filed a registration on Form S-1 with the Securities and Exchange Commission (“SEC”) for a proposed initial public offering of its common stock. The number of shares to be offered and the price range for the proposed offering have yet to be determined. LDR plans to list its common stock on the NASDAQ Global Select Market under the ticker symbol “LDRH.”
Piper Jaffray & Co., William Blair & Company, L.L.C. and Bryan, Garnier & Co. will act as joint book-running managers for the proposed offering and Cowen and Company, LLC, JMP Securities LLC and Stephens Inc. will act as co-managers.
The offering will be made only by means of a prospectus. When available, copies of the preliminary prospectus related to the offering may be obtained from Piper Jaffray & Co., Attention: Prospectus Department, 800 Nicollet Mall, J12S03, Minneapolis, MN 55402, via telephone at (800) 747-3924, or email at prospectus@pjc.com; William Blair & Company L.L.C., Attention: Prospectus Department, 222 West Adams Street, Chicago, IL 60606, telephone: (800) 621-0687, or email: prospectus@williamblair.com; or from Bryan, Garnier & Co., Attention: Prospectus Department 26, avenue des Champs-Élysées, 75008 Paris France or email: prospectus@bryangarnier.com.
A registration statement relating to these securities has been filed with the SEC but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective.
This news release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.